In vivo pharmacokinetic and anticancer studies of hh-n25, a selective inhibitor of topoisomerase i, and hormonal signaling for treating breast cancer

Bashir Lawal, Yu Cheng Kuo, Maryam Rachmawati Sumitra, Alexander T.H. Wu, Hsu Shan Huang

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'In vivo pharmacokinetic and anticancer studies of hh-n25, a selective inhibitor of topoisomerase i, and hormonal signaling for treating breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences